Equity
Share Repurchase Program - Amount Remaining
Regeneron Pharmaceuticals Share Repurchase Program - Amount Remaining decreased by 68.1% to $688.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 82.2%, from $3.87B to $688.20M.
Analysis
StatementBalance Sheet Statement
SectionEquity
First reportedQ1 2023
Last reportedQ1 2026Apr 29, 2026
Metric ID:
share_repurchase_program_amount_remainingHistorical Data
10 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.05B | $2.33B | $1.83B | $1.23B | $3.63B | $2.89B | $3.87B | $2.81B | $2.16B | $688.20M |
| QoQ Change | — | -23.6% | -21.7% | -32.5% | +194.5% | -20.3% | +33.9% | -27.4% | -23.4% | -68.1% |
| YoY Change | — | — | — | -59.6% | +55.7% | +58.4% | +214.2% | -22.5% | -25.5% | -82.2% |
Range$688.20M – $3.87B
CAGR-48.4%
Avg YoY Growth+19.8%
Median YoY Growth-22.5%
Current Streak3 quarters decline
Share Repurchase Program - Amount Remaining at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's share repurchase program - amount remaining?
- Regeneron Pharmaceuticals (REGN) reported share repurchase program - amount remaining of $688.20M in Q1 2026.
- How has Regeneron Pharmaceuticals's share repurchase program - amount remaining changed year-over-year?
- Regeneron Pharmaceuticals's share repurchase program - amount remaining decreased by 82.2% year-over-year, from $3.87B to $688.20M.